Author:
Viollier R, ,Socié G,Tichelli A,Bacigalupo A,Korthof E T,Marsh J,Cornish J,Ljungman P,Oneto R,Békássy A N,Fuehrer M,Maury S,Schrezenmeier H,van Lint M T,Wojcik D,Locasciulli A,Passweg J R
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference32 articles.
1. Passweg JR, Socie G, Hinterberger W, Bacugalupo A, Biggs JC, Camitta B et al. Bone marrow transplantation for severe aplastic anemia: has outcome improved? Blood 1997; 90: 858–864.
2. Stucki A, Leisenring W, Sandmaier BM, Sanders J, Anasetti C, Storb R . Decreased rejection and improved survival of first and second marrow transplants for severe aplastic anemia (a 26-year retrospective analysis). Blood 1998; 92: 2742–2749.
3. Ades l, Mary JY, Robin M, Ferry C, Porcher R, Esperou H et al. Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood 2004; 103: 2490–2497.
4. Locatelli F, Bruno B, Zecca M, Van Lint MT, McCann S, Arcese W et al. Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of GITMO/EBMT randomized trial. Blood 2000; 96: 1690–1697.
5. Champlin RE, Pérez WS, Passweg JR, Klein JP, Camitta BM, Gluckman E et al. Bone marrow transplantation for aplastic anemia: a randomized controlled study of conditioning regimens. Blood 2007; 109: 4582–4585.